These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 50127)

  • 1. Cancer chemotherapeutic response and intravenous hyperalimentaion.
    Lanzotti VJ; Copeland EM; George SL; Dudrick SJ; Samuels ML
    Cancer Chemother Rep; 1975; 59(2 Pt 1):437-9. PubMed ID: 50127
    [No Abstract]   [Full Text] [Related]  

  • 2. Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.
    Rosenthal CJ; Ritter S; Platica O
    Cancer Treat Rep; 1982 Jan; 66(1):205-6. PubMed ID: 6171350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of the non-small cell bronchogenic carcinoma].
    Dimitriadis K; Boutis L; Tavantzis J; Mouratidou D; Bouchoris N; Koukourikos S; Hatzigogos K; Safarini S
    Onkologie; 1983 Feb; 6(1):8-10. PubMed ID: 6189039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy with bleomycin (NSC-125066), vincristine (NSC-67574), and methotrexate (NSC-740) plus split-course radiotherapy in the treatment of non-oat-cell bronchogenic carcinoma.
    Samuels ML; Barkley HT; Holoye PY; Rosenberg PJ; Smith TL
    Cancer Chemother Rep; 1975; 59(2 Pt 1):377-83. PubMed ID: 50124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in bronchogenic carcinoma.
    Ojala A; Nikkanen VN; Palojoki A; Paloheimo S
    Ann Clin Res; 1977 Feb; 9(1):12-4. PubMed ID: 329741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy in inoperable lung cancer--a trial of 2 regimens.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1989; 31(1):21-4. PubMed ID: 2509339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of a sequential polychemotherapy (adriamycin, vincristine, cyclophosphamide, methotrexate) in small-cell and undifferentiated bronchial cancer].
    Taytard A; Chomy P; Courty G; Gachie JP; Roquain J
    Rev Fr Mal Respir; 1980; 8(3):225-32. PubMed ID: 6314444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
    Seccia A; Scafuri L; Scognamillo A; Cocco G
    G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
    [No Abstract]   [Full Text] [Related]  

  • 9. Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
    Lanzotti VJ; Thomas DR; Holoye PY; Boyle LE; Smith TL; Samuels ML
    Cancer Treat Rep; 1976 Jan; 60(1):61-8. PubMed ID: 63331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
    Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
    Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
    Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
    Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of 2 different chemotherapeutic combinations in epidermoid carcinoma of the lung. Preliminary results].
    Pipino G; Germiniani R; Maione G; Fazio FM
    Arch Sci Med (Torino); 1983; 140(2):135-8. PubMed ID: 6192792
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
    Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol].
    Adenis L; Restellini J; Caty A
    LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 20. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
    Miller CF; Weltz MD; Heim WJ; Blom J
    Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.